InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,453.85
(
1.08%
)
Post# of 63
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

NASDAQ2020

Send PM Follow Ignore
Followers 188
Posts 28685
Boards Moderated 1
Alias Born 08/29/2012

NASDAQ2020

Re: None

Saturday, 05/18/2013 2:43:23 PM

Saturday, May 18, 2013 2:43:23 PM

Post# of 63
Oxycontin- Purdue 2010 version - oxycodone provides only an incremental advantage over the very original oxycontin per the FDA
Oxecta- pfizer/King(PFE)/Acura Pharma(ACUR) - oxycodone
Acurox- King/Acura Pharma(ACUR) oxycodone / niacin
Opana ER - Endo HEALTH(ENDO) - oxymorphone 2012 ver
Exalgo - MALLINCKRODT, INC - hydromorphone
Embeda- Pfizer/King(PFE) - morphine / naltrexone - recalled for stability issues
Remoxy- Pfizer/King(PFE) Pain Therapeutics (PTIE) Durect Corp(DRRX) - oxycodone ER struggling needs additional clinical studies manufacturing issues NO COMPETITION
Deterx- Collegium- oxycodone ER

Suboxone- Reckitt-Benckiser(RBGPF) - sublingual buprenorphine / naloxone



ALO-01 Pfizer morphine/naltrexone recall unstable
ALO-02 Pfizer oxycodone/naltrexone
Acuracet- Acura- oxycodone/acetaminophen Aversion Technology
Vycavert-Acura- hydrocodone acet




http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411218/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up